Share with your friends

Deal Capsule - April 2019

Deal Capsule - April 2019

M&A activity will remain moderately strong in life sciences, with a slight slowdown in chemicals.



Christian Klingbeil

Partner, Deal Advisory - Valuation

KPMG AG Wirtschaftsprüfungsgesellschaft


Related content


Topic of this issue:

Strong start to Q1, 2019 with mega deals in both life sciences and chemicals. Big Pharma is strengthening its position in oncology through acquisitions and alliances. Financial sponsors show unabated interest in chemicals. Early-stage and digital start-ups continue to attract interest in both sectors. US and China remain the most active countries in life sciences and chemicals.

Online version

Browse directly through the publication

KPMG Deal Capsule Newsletter

© 2020 KPMG AG Wirtschaftsprüfungsgesellschaft, ein Mitglied des KPMG-Netzwerks unabhängiger Mitgliedsfirmen, die KPMG International Cooperative (“KPMG International”), einer juristischen Person schweizerischen Rechts, angeschlossen sind. Alle Rechte vorbehalten.

Connect with us


Want to do business with KPMG?


loading image Request for proposal